Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

10x Genomics, Inc. (TXG)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-K10-K
Net income  -58.2-542.7-31.3-112.5-18.8
Depreciation and amortization  21.114.07.13.94.3
Stock-based compensation  96.048.613.32.71.7
Change in working capital   [+]-43.4-20.413.7-10.71.9
Other operating activities  -36.8282.631.840.20.2
Cash from operations  -21.4-217.934.6-76.4-10.7
   
Capital expenditures  -101.3-36.7-42.7-6.3-3.8
Purchases of intangible assets   -1.70.0-0.4 
Acquisitions  -5.5    
Cash from investing  -106.7-38.4-42.8-6.7-3.8
   
Issuance of common stock, net   482.3410.8 -0.1
Option exercises  40.323.73.81.81.1
Financing costs  -5.0-5.8   
Other cash from financing  70.64.57.5107.221.8
Cash from financing  35.3468.9414.6105.420.6
   
Free cash flow  -122.7-254.6-8.1-82.7-14.5
        Per share (diluted)  ($1.11)($2.52)($0.21)($6.17)($1.25)
   
Cash paid for interest  1.21.72.31.80.7
Cash paid for income taxes  8.70.30.00.0 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy